市場調査レポート
商品コード
1368684

ヒトマイクロバイオーム市場規模:部位別、用途別、疾患別、製品別、世界予測2023-2032年

Human Microbiome Market Size - By Site (Digestive Tract, Lung), Application (Therapeutics, Diagnostics), Disease (Infectious Diseases, Gastrointestinal Diseases), Product (Drugs, Diagnostic Tests, Probiotics) & Global Forecast 2023-2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 180 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
ヒトマイクロバイオーム市場規模:部位別、用途別、疾患別、製品別、世界予測2023-2032年
出版日: 2023年08月23日
発行: Global Market Insights Inc.
ページ情報: 英文 180 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒトマイクロバイオームの世界市場シェアは、2023年から2032年にかけてCAGR 25.4%で成長します。

マイクロバイオーム研究への財政支援は科学の進歩を加速させ、革新的な治療法や診断ツールの開発につながります。

2022年7月、デュモンUCLA移植センターは、提供された臓器の生存期間を延長し、移植を受けた患者の全体的な健康と寿命を向上させることを目的とした研究活動を支援するため、連邦政府から合わせて1,150万米ドルの助成金を獲得しました。これらの助成金は、1つは国立衛生研究所から、もう1つは国防総省から提供されたもので、肝臓移植と手・顔面移植の治療成績を向上させることを目的としています。こうした投資は製薬会社やバイオテクノロジー企業を惹きつけ、協力関係を育み、市場を拡大しています。健康と病気におけるマイクロバイオームの役割を理解することに重点が置かれていることから、ヒトマイクロバイオーム産業は今後数年間で大きく成長することが予想されます。

診断分野は2032年までまずまずの成長率で拡大する可能性があります。ヒトマイクロバイオーム診断薬の需要は、マイクロバイオームが健康と疾病に果たす重要な役割に対する認識の高まりに後押しされています。研究者やヘルスケア専門家は、個人のマイクロバイオームの構成が、胃腸障害、自己免疫疾患、さらには精神的な健康問題など、さまざまな健康状態に対する貴重な洞察を提供できることを認識しつつあります。その結果、マイクロバイオームに基づく診断への関心が高まり、高度な検査・分析手法への需要が生まれています。

プロバイオティクス分野は、2032年までにヒトマイクロバイオーム産業でそこそこのシェアを獲得する可能性があります。ヒトマイクロバイオーム・プロバイオティクスは、腸の健康と全身の健康をサポートする可能性があるため、高い需要があります。これらのプロバイオティクスには有益な微生物が含まれており、消化から免疫機能まで、健康のさまざまな側面との関連性が高まっている腸内細菌叢のバランスを維持するのに役立ちます。健康増進のための自然な方法を求める消費者がマイクロバイオーム・プロバイオティクスに注目し、これらの製品に対する強い市場需要が生まれています。

アジア太平洋地域のヒトマイクロバイオーム産業は、いくつかの要因によって拡大しています。マイクロバイオームが健康に果たす極めて重要な役割に対する認識の高まりが、マイクロバイオームベースの製品やサービスに対する需要を促進しています。また、慢性的な健康状態の増加がマイクロバイオーム研究と調査療法への関心を高めています。さらに、この地域のヘルスケアインフラと研究投資の増加は、アジア太平洋地域におけるヒトマイクロバイオーム産業の成長をさらに促進しています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 ヒトマイクロバイオーム産業洞察

  • 業界情勢
  • 業界への影響要因
    • 促進要因
      • 生活習慣病の増加、高齢者人口の増加
      • 資金調達イニシアチブと政府プログラムの増加
      • 精密医療への需要の高まり
    • 業界の潜在的リスク&課題
      • 長い規制経路と高い開発コスト
      • 倫理的・安全性に関する懸念
  • 成長可能性分析
  • COVID-19影響分析
  • 規制状況
    • 米国
    • 欧州
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 企業ポジショニングマトリックス
  • 戦略ダッシュボード

第5章 ヒトマイクロバイオーム市場:部位別、2018年~2032年

  • 主要動向:部位別
  • 消化管
  • 生殖器
  • 皮膚
  • その他の部位

第6章 ヒトマイクロバイオーム市場:用途別、2018年~2032年

  • 主要動向:用途別
  • 治療薬
  • 診断薬

第7章 ヒトマイクロバイオーム市場:疾患別、2018年~2032年

  • 主要動向:疾患別
  • 感染症
  • 消化器疾患
  • 内分泌・代謝疾患
  • がん
  • 中枢神経系疾患
  • その他の疾患

第8章 ヒトマイクロバイオーム市場:製品別、2018年~2032年

  • 主要動向:製品別
  • 医薬品
  • プロバイオティクス
  • プレバイオティクス
  • 診断テスト
  • その他の製品

第9章 ヒトマイクロバイオーム市場:地域別、2018年~2032年

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他のMEA

第10章 企業プロファイル

  • Seres Therapeutics
  • Enterome
  • Second Genome Inc.
  • DuPont
  • Synthetic Biologics, Inc.
  • Synlogic
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporation
  • MICROBIOME THERAPEUTICS LLC
  • 4D pharma plc
図表

Data Tables

  • TABLE 1 Market revenue, by site (2022)
  • TABLE 2 Market revenue, by application (2022)
  • TABLE 3 Market share, by disease (2022)
  • TABLE 4 Market share, by product (2022
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global human microbiome market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global human microbiome market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 9 Global human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 10 Global human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 11 Global human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 12 Global human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 13 Global human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 14 Global human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 15 Global human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Digestive tract market size, 2018 - 2022 (USD Million)
  • TABLE 18 Digestive tract market size, 2023 - 2032 (USD Million)
  • TABLE 19 Lung market size, 2018 - 2022 (USD Million)
  • TABLE 20 Lung market size, 2023 - 2032 (USD Million)
  • TABLE 21 Reproductive cavity market size, 2018 - 2022 (USD Million)
  • TABLE 22 Reproductive cavity market size, 2023 - 2032 (USD Million)
  • TABLE 23 Skin market size, 2018 - 2022 (USD Million)
  • TABLE 24 Skin market size, 2023 - 2032 (USD Million)
  • TABLE 25 Other sites market size, 2018 - 2022 (USD Million)
  • TABLE 26 Other sites market size, 2023 - 2032 (USD Million)
  • TABLE 27 Therapeutics market size, 2018 - 2022 (USD Million)
  • TABLE 28 Therapeutics market size, 2023 - 2032 (USD Million)
  • TABLE 29 Diagnostics market size, 2018 - 2022 (USD Million)
  • TABLE 30 Diagnostics market size, 2023 - 2032 (USD Million)
  • TABLE 31 Infectious diseases market size, 2018 - 2022 (USD Million)
  • TABLE 32 Infectious diseases market size, 2023 - 2032 (USD Million)
  • TABLE 33 Gastrointestinal diseases market size, 2018 - 2022 (USD Million)
  • TABLE 34 Gastrointestinal diseases market size, 2023 - 2032 (USD Million)
  • TABLE 35 Endocrine & metabolic diseases market size, 2018 - 2022 (USD Million)
  • TABLE 36 Endocrine & metabolic diseases market size, 2023 - 2032 (USD Million)
  • TABLE 37 Cancer market size, 2018 - 2022 (USD Million)
  • TABLE 38 Cancer market size, 2023 - 2032 (USD Million)
  • TABLE 39 Central nervous system disorder market size, 2018 - 2022 (USD Million)
  • TABLE 40 Central nervous system disorder market size, 2023 - 2032 (USD Million)
  • TABLE 41 Other diseases market size, 2018 - 2022 (USD Million)
  • TABLE 42 Other diseases market size, 2023 - 2032 (USD Million)
  • TABLE 43 Drug market size, 2018 - 2022 (USD Million)
  • TABLE 44 Drug market size, 2023 - 2032 (USD Million)
  • TABLE 45 Probiotics market size, 2018 - 2022 (USD Million)
  • TABLE 46 Probiotics market size, 2023 - 2032 (USD Million)
  • TABLE 47 Prebiotics market size, 2018 - 2022 (USD Million)
  • TABLE 48 Prebiotics market size, 2023 - 2032 (USD Million)
  • TABLE 49 Diagnostic tests market size, 2018 - 2022 (USD Million)
  • TABLE 50 Diagnostic tests market size, 2023 - 2032 (USD Million)
  • TABLE 51 Other products market size, 2018 - 2022 (USD Million)
  • TABLE 52 Other products market size, 2023 - 2032 (USD Million)
  • TABLE 53 North America human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 54 North America human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 55 North America human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 56 North America human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 57 North America human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 58 North America human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 59 North America human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 60 North America human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 61 North America human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 62 North America human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 63 U.S. human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 64 U.S. human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 65 U.S. human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 66 U.S. human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 67 U.S. human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 68 U.S. human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 69 U.S. human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 70 U.S. human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 71 Canada human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 72 Canada human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 73 Canada human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 74 Canada human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 75 Canada human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 76 Canada human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 77 Canada human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 78 Canada human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 79 Europe human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 80 Europe human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 81 Europe human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 82 Europe human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 83 Europe human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 84 Europe human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 85 Europe human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 86 Europe human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 87 Europe human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 88 Europe human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 89 Germany human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 90 Germany human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 91 Germany human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 92 Germany human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 93 Germany human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 94 Germany human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 95 Germany human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 96 Germany human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 97 UK human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 98 UK human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 99 UK human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 100 UK human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 101 UK human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 102 UK human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 103 UK human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 104 UK human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 105 France human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 106 France human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 107 France human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 108 France human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 109 France human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 110 France human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 111 France human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 112 France human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 113 Spain human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 114 Spain human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 115 Spain human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 116 Spain human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 117 Spain human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 118 Spain human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 119 Spain human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 120 Spain human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 121 Italy human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 122 Italy human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 123 Italy human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 124 Italy human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 125 Italy human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 126 Italy human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 127 Italy human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 128 Italy human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 129 Rest of Europe human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 130 Rest of Europe human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 131 Rest of Europe human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 132 Rest of Europe human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 133 Rest of Europe human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 134 Rest of Europe human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 135 Rest of Europe human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 136 Rest of Europe human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 137 Asia Pacific human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 138 Asia Pacific human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 139 Asia Pacific human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 140 Asia Pacific human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 141 Asia Pacific human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 142 Asia Pacific human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 143 Asia Pacific human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 144 Asia Pacific human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 145 Asia Pacific human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 146 Asia Pacific human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 147 Japan human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 148 Japan human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 149 Japan human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 150 Japan human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 151 Japan human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 152 Japan human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 153 Japan human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 154 Japan human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 155 China human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 156 China human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 157 China human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 158 China human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 159 China human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 160 China human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 161 China human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 162 China human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 163 India human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 164 India human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 165 India human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 166 India human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 167 India human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 168 India human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 169 India human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 170 India human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 171 Australia human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 172 Australia human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 173 Australia human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 174 Australia human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 175 Australia human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 176 Australia human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 177 Australia human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 178 Australia human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 179 Rest of Asia Pacific human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 180 Rest of Asia Pacific human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 181 Rest of Asia Pacific human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 182 Rest of Asia Pacific human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 183 Rest of Asia Pacific human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 184 Rest of Asia Pacific human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 185 Rest of Asia Pacific human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 186 Rest of Asia Pacific human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 187 Latin America human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 188 Latin America human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 189 Latin America human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 190 Latin America human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 191 Latin America human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 192 Latin America human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 193 Latin America human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 194 Latin America human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 195 Latin America human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 196 Latin America human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 197 Brazil human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 198 Brazil human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 199 Brazil human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 200 Brazil human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 201 Brazil human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 202 Brazil human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 203 Brazil human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 204 Brazil human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 205 Mexico human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 206 Mexico human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 207 Mexico human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 208 Mexico human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 209 Mexico human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 210 Mexico human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 211 Mexico human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 212 Mexico human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 213 Rest of Latin America human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 214 Rest of Latin America human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 215 Rest of Latin America human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 216 Rest of Latin America human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 217 Rest of Latin America human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 218 Rest of Latin America human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 219 Rest of Latin America human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 220 Rest of Latin America human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 221 Middle East & Africa human microbiome market size, by country, 2018 - 2022 (USD Million)
  • TABLE 222 Middle East & Africa human microbiome market size, by country, 2023 - 2032 (USD Million)
  • TABLE 223 Middle East & Africa human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 224 Middle East & Africa human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 225 Middle East & Africa human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 226 Middle East & Africa human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 227 Middle East & Africa human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 228 Middle East & Africa human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 229 Middle East & Africa human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 230 Middle East & Africa human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 231 Saudi Arabia human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 232 Saudi Arabia human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 233 Saudi Arabia human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 234 Saudi Arabia human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 235 Saudi Arabia human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 236 Saudi Arabia human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 237 Saudi Arabia human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 238 Saudi Arabia human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 239 South Africa human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 240 South Africa human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 241 South Africa human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 242 South Africa human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 243 South Africa human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 244 South Africa human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 245 South Africa human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 246 South Africa human microbiome market size, by product, 2023 - 2032 (USD Million)
  • TABLE 247 Rest of Middle East & Africa human microbiome market size, by site, 2018 - 2022 (USD Million)
  • TABLE 248 Rest of Middle East & Africa human microbiome market size, by site, 2023 - 2032 (USD Million)
  • TABLE 249 Rest of Middle East & Africa human microbiome market size, by application, 2018 - 2022 (USD Million)
  • TABLE 250 Rest of Middle East & Africa human microbiome market size, by application, 2023 - 2032 (USD Million)
  • TABLE 251 Rest of Middle East & Africa human microbiome market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 252 Rest of Middle East & Africa human microbiome market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 253 Rest of Middle East & Africa human microbiome market size, by product, 2018 - 2022 (USD Million)
  • TABLE 254 Rest of Middle East & Africa human microbiome market size, by product, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Market estimation and forecast methodology
  • FIG 3 Market forecasting methodology
  • FIG 4 Breakdown of primary participants
  • FIG 5 Human microbiome industry 360 degree synopsis, 2018 - 2032
  • FIG 6 Growth potential analysis, by site
  • FIG 7 Growth potential analysis, by application
  • FIG 8 Growth potential analysis, by disease
  • FIG 9 Growth potential analysis, by product
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Competitive analysis of major market players, 2022
  • FIG 14 Competitive positioning matrix
  • FIG 15 Strategic dashboard, 2022
目次
Product Code: 6538

Global Human Microbiome Market share will grow at 25.4% CAGR between 2023 and 2032, driven by the increasing funding initiatives and government programs worldwide prioritizing research in this field. Financial support for microbiome research accelerates scientific advancements, leading to the development of innovative therapies and diagnostic tools.

In July 2022, the Dumont-UCLA Transplant Center secured a combined $11.5 million in federal government grants to support research endeavors with the goal of extending the viability of donated organs and enhancing the overall health and longevity of transplant recipients. These grants, one provided by the National Institutes of Health and the other by the Department of Defense, are dedicated to advancing the outcomes of liver transplantation and hand and face transplantation. These investments attract pharmaceutical and biotechnology companies, fostering collaborations and expanding the market. The emphasis on understanding the role of the microbiome in health and disease positions the human microbiome industry for significant growth in the coming years.

The overall human microbiome market is segregated based on site, application, disease, product, and region.

The diagnostics segment could expand at a decent growth rate through 2032. The demand for human microbiome diagnostics is propelled by the growing awareness of the significant role the microbiome plays in health and disease. Researchers and healthcare professionals are increasingly recognizing that the composition of an individual's microbiome can provide valuable insights into various health conditions, including gastrointestinal disorders, autoimmune diseases, and even mental health issues. As a result, there's a rising interest in microbiome-based diagnostics, creating a demand for advanced testing and analysis methods.

The probiotics segment could capture a modest human microbiome industry share by 2032. Human microbiome probiotics are in high demand due to their potential to support gut health and overall well-being. These probiotics contain beneficial microorganisms that can help maintain a balanced gut microbiome, which is increasingly linked to various aspects of health, from digestion to immune function. Consumers seeking natural ways to improve their health are turning to microbiome probiotics, creating a strong market demand for these products.

Asia Pacific human microbiome industry is expanding due to several factors. A growing awareness of the pivotal role the microbiome plays in health is driving demand for microbiome-based products and services. Besides, the rise in chronic health conditions has spurred interest in microbiome research and therapies. Moreover, the region's increasing healthcare infrastructure and research investments further facilitate the growth of the human microbiome industry in the Asia Pacific.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Global human microbiome industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Site trends
    • 2.1.4 Application trends
    • 2.1.5 Disease trends
    • 2.1.6 Product trends

Chapter 3 Human Microbiome Industry Insights

  • 3.1 Industry landscape
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing burden of lifestyle-related diseases and the growing geriatric population
      • 3.2.1.2 Increasing funding initiatives and government program
      • 3.2.1.3 Increasing demand precision medicine
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Long regulatory pathways and high development costs
      • 3.2.2.2 Ethical and safety concern
  • 3.3 Growth potential analysis
    • 3.3.1 By site
    • 3.3.2 By application
    • 3.3.3 By disease
    • 3.3.4 By product
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Company positioning matrix
  • 4.5 Strategy dashboard, 2022

Chapter 5 Human Microbiome Market, By Site, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by site
  • 5.2 Digestive tract
  • 5.3 Lung
  • 5.4 Reproductive cavity
  • 5.5 Skin
  • 5.6 Other sites

Chapter 6 Human Microbiome Market, By Application, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Therapeutics
  • 6.3 Diagnostics

Chapter 7 Human Microbiome Market, By Disease, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by disease
  • 7.2 Infectious diseases
  • 7.3 Gastrointestinal diseases
  • 7.4 Endocrine & metabolic diseases
  • 7.5 Cancer
  • 7.6 Cetral nervous system disorder
  • 7.7 Other diseases

Chapter 8 Human Microbiome Market, By Product, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by product
  • 8.2 Drugs
  • 8.3 Probiotics
  • 8.4 Prebiotics
  • 8.5 Diagnostic tests
  • 8.6 Other products

Chapter 9 Human Microbiome Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 Seres Therapeutics
  • 10.2 Enterome
  • 10.3 Second Genome Inc.
  • 10.4 DuPont
  • 10.5 Synthetic Biologics, Inc.
  • 10.6 Synlogic
  • 10.7 Vedanta Biosciences, Inc.
  • 10.8 Metabiomics Corporation
  • 10.9 MICROBIOME THERAPEUTICS LLC
  • 10.10 4D pharma plc